FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
7237811000172118 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


15419 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
T4a: Breast tumor with extension to chest wall American Joint Committee on Cancer cT4a (qualifier value)
T4a: Colon/rectum tumor directly invades other organs or structures American Joint Committee on Cancer cT4a (qualifier value)
T4b: Bladder tumor invades pelvic wall or abdominal wall cT4b
T4b: Colon/rectum tumor penetrates the visceral peritoneum cT4b
T4b: Edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast cT4b
T4c: Breast tumor, both T4a and T4b American Joint Committee on Cancer cT4c (qualifier value)
T4d: Inflammatory carcinoma (breast) American Joint Committee on Cancer cT4d (qualifier value)
T4d: Inflammatory carcinoma of breast with involvement of skin and chest wall by carcinoma American Joint Committee on Cancer cT4d (qualifier value)
TNM tumour staging American Joint Committee on Cancer allowable value
TNM tumour staging American Joint Committee on Cancer allowable value
stade TX American Joint Committee on Cancer cTX (qualifier value)
Ta: Noninvasive papillary carcinoma (urinary tract) American Joint Committee on Cancer cTa (qualifier value)
Tacrolimus 0.03% ointment Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug)
Tacrolimus 0.1% ointment Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Tacrolimus 1mg modified-release tablet Tacrolimus only product in oral dose form
Tacrolimus 1mg prolonged-release oral tablet Tacrolimus only product in oral dose form
Tacrolimus 4mg modified-release tablet Tacrolimus only product in oral dose form
Tacrolimus 4mg prolonged-release oral tablet Tacrolimus only product in oral dose form
Tacrolimus 5mg/1mL infusion concentrate Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Tacrolimus 5mg/mL infusion concentrate 1mL ampule Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Tacrolimus 5mg/mL injection Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Tacrolimus 5mg/mL injection solution 1mL vial Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Tacrolimus 750microgram modified-release tablet Tacrolimus only product in oral dose form
Tacrolimus 750microgram prolonged-release orale tablet Tacrolimus only product in oral dose form
Tacrolimus monohydrate 0.03% ointment Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug)
Tacrolimus monohydrate 0.1% ointment Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Taenia multiceps Taenia multiceps
Take-down of arteriovenous shunt Removal of arteriovenous shunt device
afname van uitstrijk met wattenstok voor onderzoek naar specifiek organisme Taking swab for microbiology
prélèvement par écouvillonnage d'un site anatomique Taking of swab
Tamoxifen 10mg tablet Product containing precisely tamoxifen (as tamoxifen citrate) 10 milligram/1 each conventional release oral tablet (clinical drug)
Tamoxifen 20mg tablet Product containing precisely tamoxifen (as tamoxifen citrate) 20 milligram/1 each conventional release oral tablet (clinical drug)
Tamoxifen citrate 10mg Product containing precisely tamoxifen (as tamoxifen citrate) 10 milligram/1 each conventional release oral tablet (clinical drug)
Tamoxifen citrate 10mg tablet Product containing precisely tamoxifen (as tamoxifen citrate) 10 milligram/1 each conventional release oral tablet (clinical drug)
Tamsulosin hydrochloride 400micrograms m/r tablet Tamsulosin only product in oral dose form
Tamsulosin hydrochloride 400micrograms prolonged-release oral tablet Tamsulosin only product in oral dose form
Tannin Tannic acid
Tapeworm larvae Class Cestoda larva
Tardive dyskinesia Tardive dyskinesia
Teacher of the mentally handicapped Intellectual disability teacher
Technetium Tc^99c^ medronate Technetium (99m-Tc) medronate (substance)
Technetium[99mTc] albumin colloid (nanosized) injection Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form)
Technetium[99mTc] albumin colloid (nanosized) injection Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form)
Technetium[99mTc] albumin millimicrospheres injection Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form)
Technetium[99mTc] albumin millimicrospheres injection Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form)
gebitselementen bedekt met plaque Dental plaque on teeth
Teichococcus ludipueritiae Roseomonas ludipueritiae (organism)
Telephoned report Telephoned report (record artifact)
Teleradiotherapy of unlisted particulate radiation External beam radiation therapy procedure
Teletherapy with radium collar Radium therapy (procedure)
Temperature of blood Core body temperature measured in blood (observable entity)
Temporary code for ultrastructural feature Subcellular structure
Temporary urinary catheter Urinary catheter
Temsirolimus 25mg/mL injection solution vial + diluent Temsirolimus only product
Temsirolimus 25mg/mL powder for conventional release solution for injection vial Temsirolimus only product
Tendon lengthening procedure Surgical lengthening - action
Tendon transfer procedure Surgical transfer - action
tendoperiostitis Tenoperiostitis (disorder)
Tenecteplase 8000iu(40mg) powder and solvent for injection solution vial Product containing only tenecteplase (medicinal product)
Tenecteplase 8000iu(40mg) powder for conventional release solution for injection vial Product containing only tenecteplase (medicinal product)
Teniposide 10mg/mL injection solution 5mL vial Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Teniposide 50mg injection solution ampule Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Tenosynovitis of foot and ankle, NEC Tenosynovitis
Tenosynovitis of hand and wrist, NEC Tenosynovitis
Tenure - Dentine bonding agent Dentine bonding agent (substance)
Tenure of accommodation Tenure of accommodation
Teratoma - category Teratoma
Teratoma, malignant, no International Classification of Diseases for Oncology subtype Malignant teratoma (morphologic abnormality)
Teratoma, no International Classification of Diseases for Oncology subtype Teratoma of uncertain behavior (morphologic abnormality)
Terazosin hydrochloride 10mg Terazosin (as terazosin hydrochloride) 10 mg oral capsule
Terazosin hydrochloride 1mg Terazosin (as terazosin hydrochloride) 1 mg oral capsule
Terazosin hydrochloride 5mg Terazosin (as terazosin hydrochloride) 5 mg oral capsule
Terbinafine hydrochloride 1% gel Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous gel
Terbutaline sulfate 0.2mg/inh aerosol Terbutaline sulfate 200 microgram/mL solution for inhalation
Terbutaline sulfate 200mg/20mL nebulizer solution Terbutaline sulfate 10 mg/mL solution for inhalation
Terbutaline sulfate 5mg/2mL nebulization unit Terbutaline sulfate 2.5 mg/mL solution for inhalation
Terlipressin 1mg powder and solvent for injection solution vial Terlipressin only product
Terlipressin 1mg powder for conventional release solution for injection vial Terlipressin only product
Termination of pregnancy Induced termination of pregnancy (procedure)
Termination of pregnancy operation NOS Operative termination of pregnancy
Termination of pregnancy operation NOS Operative termination of pregnancy
Terodiline hydrochloride adverse reaction Adverse reaction to terodiline (disorder)
Terrestrial mollusk - dietary Terrestrial mollusk (substance)
Testicular hypogonadism Male hypogonadism
prélèvement de sperme testiculaire par aspiration Aspiration of seminal fluid from testis (procedure)
Testis TNM finding American Joint Committee on Cancer allowable value
Testosterone 1% gel Testosterone only product
Testosterone 30mg buccal system Testosterone 30 mg buccal film
Testosterone 50mg gel 5g sachet Testosterone 10 mg/g cutaneous gel
Testosterone cypionate 100mg/mL injection solution ampule Product containing only testosterone in parenteral dose form (medicinal product form)
Testosterone cypionate 200mg/cc Product containing only testosterone in parenteral dose form (medicinal product form)
Testosterone cypionate 200mg/mL Product containing only testosterone in parenteral dose form (medicinal product form)
Testosterone cypionate 200mg/mL injection solution ampule Product containing only testosterone in parenteral dose form (medicinal product form)
Testosterone implant Testosterone-containing product in parenteral dose form
Testosterone implant allergy Allergy to testosterone
Testosterone patch allergy Allergy to testosterone
Tetanus and low dose diphtheria double vaccination Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure)
Tetanus and low dose diphtheria double vaccination Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure)
Tetanus and low dose diphtheria double vaccination Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure)
Tetanus immunization Administration of tetanus vaccine
Tetracaine hydrochloride 0.3%/dextrose 6% injection solution Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug)

Start Previous Page 134 of 155 Next End


Reference Sets

Reference set descriptor

Back to Start